IVF Michigan Fertility Center's state-of-the-art facility utilizes the latest technologies including an in-house embryo genetic testing laboratory allowing for embryo micromanipulation in addition to a lab for sperm processing. IVF Michigan Fertility Center is committed to fulfilling dreams of parenthood by delivering compassionate and personalized fertility treatments that are provided by a team of specialized medical experts equipped with the most advanced technology and innovative medical protocols.
With today’s advanced reproductive technologies, identifying the gender of your embryos before pregnancy is possible through IVF and comprehensive chromosomal screening through Pre-Implantation Genetic Screening (PGS). The combined method of PGS and IVF is the most accurate method available today, with accuracy nearing 100%. IVF Michigan Fertility Center offers Family Balancing through Gender Selection in all of our five locations across the Midwest. With over 60 years of collective experience and locations in Bloomfield Hills, Ann Arbor, Dearborn, Saginaw and Toledo, OH, the physicians of IVF Michigan Fertility Center are available to help couples throughout the Midwest and abroad.
What is Pre-Implantation Genetic Screening?
Pre-Implantation Genetic Screening (PGS), also known as “embryo screening”, is a test performed on a few cells obtained from the embryo and provides the following benefits:
- Check all 24 chromosomes for any chromosomal abnormality such as Down syndrome and Edward's syndrome
- Identify the gender of embryos
- Embryos without chromosomal abnormalities are at reduced risk for miscarriage
What are the steps involved in PGS for Gender Selection?
Completing PGS with an IVF-ICSI cycle does not change the duration of treatment. Following Egg Retrieval, if the eggs are fertilized successfully, a biopsy is taken from each embryo and tested through PGS. The healthy embryos of the desired gender are then transferred to the uterus. The following steps take place over 15 to 20 days.
Ovarian Stimulation (7 to 10 days):
On Day 2 or 3 of the Menstrual cycle, medication is prescribed to stimulate the growth of multiple follicles in the ovaries. During this time, follicular growth is monitored through ultrasound as they develop into eggs and hormone levels are tracked through blood tests. Medication protocols are changed as needed. 36 – 40 hours before the scheduled Egg Retrieval, a “trigger” shot is given to induce maturation of the eggs within a scheduled timeframe.
Egg Retrieval (OPU):
Eggs are retrieved using a thin ultrasound-guided needle during a short procedure under sedation. The number of eggs retrieved depends on the body's response to the medication.
Sperm Collection and ICSI:
On the day of Egg Retrieval, a semen sample is taken to fertilize the retrieved eggs. To increase chances of fertilization, a single sperm is injected into each egg using a precision needle in a method called ICSI.
Pre-Implantation Genetic Screening (PGS):
Pre-Implantation Genetic Screening (PGS) will be completed for family balancing or to screen for any chromosomal abnormalities. 3 to 5 days after the Egg Retrieval, a biopsy is taken from each embryo and tested in the Genetics Lab. The health and gender of the embryos is identified and discussed with you before Embryo Transfer.
Embryo Transfer (ET):
Embryo Transfer is a minor procedure that does not require sedation. Following the procedure, hormone levels are tracked through blood test to confirm pregnancy. Any embryos that are not transferred may be frozen and used in a future cycle.